INM-901 significantly reduced pro-inflammatory cytokines associated with Alzheimer'sStatistically significant reduction in ...
Another challenge is the stability of mRNA molecules. Efforts are being made to engineer mRNA with enhanced stability and reduced immunogenicity to improve its therapeutic efficacy and safety profile.
CAMBRIDGE, MA / ACCESSWIRE / January 13, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced business updates and progress across its pipeline of mRNA medicines. Moderna enters 2025 with a focus on ...
A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine.
A global international trial of an mRNA vaccine against norovirus is getting underway with the aim of reducing the health burden caused by the infamous “winter vomiting” bug. The trial has ...
Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN. The CDC issued a health advisory Thursday ...